Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: A population-based study

Journal of the Chinese Medical Association

Volumn 80, Issue 2, 2017, Pages 56-62

  Hsu, Yung Cheng ^a   Wu, Tzee Chung ^a,b   Lo, Yu Cheng ^a   Wang, Li Shu ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Crohn's disease; extraintestinal manifestations; inflammatory bowel disease; ulcerative colitis

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ANUS FISSURE; ANUS FISTULA; ARTERIAL THROMBOEMBOLISM; ARTHRITIS; ARTICLE; BRONCHIECTASIS; CHOLANGITIS; CLINICAL FEATURE; COLON TUMOR; COLORECTAL CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EPISCLERITIS; ERYTHEMA NODOSUM; FEMALE; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; HUMAN; INCIDENCE; INTESTINE FISTULA; INTESTINE INFECTION; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; IRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OSTEOPOROSIS; PANCREATITIS; PERIANAL ABSCESS; PERIPHERAL NEUROPATHY; PERITONITIS; POPULATION RESEARCH; PREVALENCE; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDY; SCLERITIS; SEX DIFFERENCE; TAIWAN; ULCERATIVE COLITIS; UVEITIS; VENOUS THROMBOEMBOLISM; COMPLICATION; GASTROINTESTINAL DISEASES; MIDDLE AGED;

ADULT; CROHN DISEASE; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAIWAN;

EID: 85013093631     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2016.08.009     Document Type: Article

References (38)

1. 1 Podolsky, D.K., Inflammatory bowel disease. N Engl J Med 347 (2002), 417–429.
2. 2 Fiocchi, C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998), 182–205.
3. 3 Thoreson, R., Cullen, J.J., Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am 87 (2007), 575–585.
4. 4 Larsen, S., Bendtzen, K., Nielsen, O.H., Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42 (2010), 97–114.
5. 5 Kim, E.S., Kim, W.H., Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 4 (2010), 1–14.
6. 6 Ye, L., Cao, Q., Cheng, J., Review of inflammatory bowel disease in china. Sci World J, 2013, 2013, 296470.
7. 7 Prideaux, L., Kamm, M.A., De Cruz, P.P., Chan, F.K., Ng, S.C., Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 27 (2012), 1266–1280.
8. 8 Chuang, C.H., Lin, S.H., Chen, C.Y., Sheu, B.S., Kao, A.W., Wang, J.D., Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998–2010. Inflamm Bowel Dis 19 (2013), 2815–2819.
9. 9 Department of household Registration. Available at: http://www.ris.gov.tw/346. [Accessed 20 October 2016] [In Chinese].
10. 10 Administration NHI. Available at: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id=1023&WD_ID=1043&webdata_id=4640. [Accessed 20 October 2016] [In Chinese].
11. 11 Ott, C., Scholmerich, J., Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol 10 (2013), 585–595.
12. 12 Ramadas, A.V., Gunesh, S., Thomas, G.A., Williams, G.T., Hawthorne, A.B., Natural history of Crohn's disease in a population-based cohort from C (1986–2003): a study of changes in medical treatment and surgical resection rates. Gut 59 (2010), 1200–1206.
13. 13 Freeman, H.J., Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol 39 (2005), 774–777.
14. 14 Freeman, H.J., Natural history and long-term clinical course of Crohn's disease. World J Gastroenterol 20 (2014), 31–36.
15. 15 Singh, B., Mc, C.M.N.J., Jewell, D.P., George, B., Perianal Crohn's disease. Br J Surg 91 (2004), 801–814.
16. 16 Wang, Y.F., Zhang, H., Ouyang, Q., Clinical manifestations of inflammatory bowel disease: east and west differences. J Dig Dis 8 (2007), 121–127.
17. 17 Wang, F.W., Hsu, P.I., Chuang, H.Y., Tu, M.S., Mar, G.Y., King, T.M., et al. Prevalence and risk factors of asymptomatic colorectal polyps in Taiwan. Gastroenterol Res Pract, 2014, 2014, 985205.
18. 18 Kitiyakara, T., Bailey, D.M., McIntyre, A.S., Gorard, D.A., Adenomatous colonic polyps are rare in ulcerative colitis. Aliment Pharmacol Ther 19 (2004), 879–887.
19. 19 Eaden, J.A., Abrams, K.R., Mayberry, J.F., The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001), 526–535.
20. 20 Potack, J., Itzkowitz, S.H., Colorectal cancer in inflammatory bowel disease. Gut Liver 2 (2008), 61–73.
21. 21 Bernstein, C.N., Blanchard, J.F., Kliewer, E., Wajda, A., Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001), 854–862.
22. 22 Levine, J.S., Burakoff, R., Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 7 (2011), 235–241.
23. 23 Ardizzone, S., Puttini, P.S., Cassinotti, A., Porro, G.B., Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis, 40, 2008 60534–4.
24. 24 Ng, S.C., Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol 28 (2014), 363–372.
25. 25 Lakatos, L., Pandur, T., David, G., Balogh, Z., Kuronya, P., Tollas, A., et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 9 (2003), 2300–2307.
26. 26 Orchard, T.R., Wordsworth, B.P., Jewell, D.P., Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42 (1998), 387–391.
27. 27 De Vos, M., Joint involvement associated with inflammatory bowel disease. Dig Dis 27 (2009), 511–515.
28. 28 Palm, O., Moum, B., Jahnsen, J., Gran, J.T., The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 40 (2001), 1256–1261.
29. 29 Vavricka, S.R., Rogler, G., Gantenbein, C., Spoerri, M., Prinz Vavricka, M., Navarini, A.A., et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis 21 (2015), 1794–1800.
30. 30 Brakenhoff, L.K., van der Heijde, D.M., Hommes, D.W., Huizinga, T.W., Fidder, H.H., The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis 4 (2010), 257–268.
31. 31 Perez-Alamino, R., Maldonado-Ficco, H., Maldonado-Cocco, J.A., Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35 (2016), 291–296.
32. 32 Powell, F.C., Su, W.P., Perry, H.O., Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34 (1996), 395–409 quiz 10–2.
33. 33 Trost, L., McDonnell, J., Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 81 (2005), 580–585.
34. 34 Marzano, A.V., Borghi, A., Stadnicki, A., Crosti, C., Cugno, M., Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20 (2014), 213–227.
35. 35 Farhi, D., Cosnes, J., Zizi, N., Chosidow, O., Seksik, P., Beaugerie, L., et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 87 (2008), 281–293.
36. 36 Weizman, A., Huang, B., Berel, D., Targan, S.R., Dubinsky, M., Fleshner, P., et al. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis 20 (2014), 525–533.
37. 37 Yarur, A.J., Czul, F., Levy, C., Hepatobiliary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 20 (2014), 1655–1667.
38. 38 Wei, S.C., Shieh, M.J., Chang, M.C., Chang, Y.T., Wang, C.Y., Wong, J.M., Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc 75 (2012), 151–155.